Live Breaking News & Updates on Simon Family Trust
Stay updated with breaking news from Simon family trust. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Overcoming Obstacles to Promote Repair in Multiple Sclerosis prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Overcoming Obstacles to Promote Repair in Multiple Sclerosis prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Overcoming Obstacles to Promote Repair in Multiple Sclerosis menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Overcoming Obstacles to Promote Repair in Multiple Sclerosis menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
4.9 (16) A $2.5 million donation from the Simon Family Trust is supporting the creation of a new center of expertise to help in the development of new therapies for multiple sclerosis (MS) and other neurological diseases. The new center is being launched by researchers from Gladstone Institutes and the University of California San Francisco (UCSF) and is called Gladstone-UCSF Center for Neurovascular Brain Immunology. It will combine basic and clinical research in vascular biology (the study of blood vessels), immunology, and neuroscience to discover new mechanisms that may control disease. Clinical manifestations of neurological diseases like MS result from a complex network of mechanisms shared between the brain, and the immune and vascular systems. Although these mechanisms overlap, they have been studied separately, which may be hindering the study of potential therapies. ....